Study: Drug firms fund health advocacy groups

January 14, 2011

Many health advocacy organizations rely on financial support from drug companies. But few disclose the extent of that funding or make information easily accessible, according to a new report published Thursday by researchers at Columbia University’s Mailman School of Public Health. (Los Angeles Times)

Posted by

Posted in Biotech, News